Cardlytics (CDLX) Tops Q3 EPS by 66c
Cardlytics (NASDAQ: CDLX) reported Q3 EPS of $0.01, $0.66 better than the analyst estimate of ($0.65). Revenue for the quarter came in at $79 million versus the consensus estimate of $80.01 million.
For earnings history and earnings-related data on Cardlytics (CDLX) click here.
